3D Printed Drugs Market: By Drugs(Spritam, Others), By Applications(Neurology, Orthopedic, Hearing and Audibility Aid, Dental, Medical Implants, Other), By End-Users(Hospitals, Clinics, Research Laboratories)

Report ID: BMRC 737 | Number of pages: 196 | Publish Date: Aug 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New
Global 3D Printed Drugs market is valued at USD 272.17million in 2018 and expected to reach USD 437.04 million by 2025 with a CAGR of 7.0 % over the forecast period. Increase in demand for fast soluble drugs which can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market.
  

Scope of 3D Printed Drugs Market Report:

3D printed drugs are medications, which are designed by 3D printing technique to modify for individuals in a safe and effective way. 3D printed drugs are developed by using powder-liquid three dimensional printing technologies. This technique uses an aqueous fluid which is able to bind different or similar layer of powders and produces multiple types of products. Additionally, 3D printed drugs are able to liquefy unsolvable compounds such as silver chloride very easily. The main objective and one of the major benefits of 3D printed drugs is how they will be able to be constructed with an individual’s specific requirements in mind, and even created in line with certain preferences. Factors like the size, dose, appearance and rate of delivery of a drug can be controlled. So, during the study of 3D printed drugs market, we have considered 3D printed drugs and therapy to analyze the market. Global 3D Printed Drugs Market report is segmented on the basis of drug, end users, applications and by regional & country level. Based upon drug, global 3D printed drugs market is segmented into spritam and others. Based upon applications, global 3D printed drugs market is segmented as neurology, orthopedic, hearing and audibility aid, dental, medical implants and others. Based upon end users global 3D printed drugs market is segmented into hospitals, clinics and research laboratories. The regions covered in this 3D printed drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of 3D Printed Drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc. Key Players for Global 3D Printed Drugs Market Reports- Some major key players for global 3D Printed Drugs market are 3D Printer Drug Machine, Aprecia Pharmaceuticals, Hewlett Packard Caribe, BV, LLC, GlaxoSmithKline Plc., FabRx Ltd., Cycle Pharmaceuticals and others. In 2017, Aprecia Pharmaceuticals and Cycle Pharmaceuticals have signed a partnership agreement to develop and commercialized orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-oflife improvements versus existing, approved orphan’s drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose Technology platform. ZipDose is the only three dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration. Global 3D Printed Drugs Market Dynamics – Continuous technological development in 3D printing techniques, increase in awareness about the 3D printing technology in developing countries and rise in incidence of epilepsy cases drive the growth of the market. According to WHO, Epilepsy accounts for a significant proportion of the world‘s disease burden, affecting more than 50 million people worldwide. The expected proportion of the general population with active epilepsy at a given time is between 4 and 10 per 1000 people. But some studies in low-and middle-income countries suggest that the proportion is higher, between 7 and 15 per 1000 people. Moreover with the point of view on diagnosed rate globally, an estimated 2.4 million people are diagnosed with epilepsy each year. Also, lack of government regulations related to these drugs and adverse effect of 3D printed drugs are expected to limit the market growth. Nonetheless, big pharmaceuticals companies are heavily investing into the 3D printing drug technology and are expected to enter into this market in near future. The global 3D printed drugs market is segmented into North America, Europe, Asia-Pacific and Rest of the World (ROW). North America dominates 3D printed drugs market due to their pharmaceutical companies presents worldwide along with them having a strong domestic healthcare infrastructure. The pharmaceutical sector is highly dependent on R&D spending which also explains their continued dominance. Asia Pacific countries like China and India are expected to record the highest growth in the 3D printed drugs market due to massive investments in both R&D & the pharmaceutical industry. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global 3D Printed Drugs Market. Key Benefits for 3D Printed Drugs Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Global 3D Printed Drugs Market Segmentation

By Drugs: • Spritam • Others By Applications: • Neurology • Orthopedic • Hearing and Audibility Aid • Dental, Medical Implants • Other By End-Users: • Hospitals • Clinics and • Research Laboratories By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa 3D Printed Drugs Market Key Players: • 3D Printer Drug Machine • Aprecia Pharmaceuticals • Hewlett Packard Caribe • BV • LLC • GlaxoSmithKline Plc. • FabRx Ltd. • Cycle Pharmaceuticals • Other This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global 3D Printed Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global 3D Printed Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. 3D Printed Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global 3D Printed Drugs Market Overview: Quantitative Analysis
3.1. Global 3D Printed Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global 3D Printed Drugs Market Revenue Market Share (%), 2014- 2025
3.3. Global 3D Printed Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global 3D Printed Drugs Market Sales Market Share (%), 2014- 2025
4. Chapter – Global 3D Printed Drugs Market Analysis: By Drugs 
5. Chapter – Global 3D Printed Drugs Market Analysis: By Application
6. Chapter – Global 3D Printed Drugs Market Analysis: By End-User
7. Chapter - Global 3D Printed Drugs Market Analysis: By Manufacturer
7.1. Global 3D Printed Drugs Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global 3D Printed Drugs Market Share (%), by Manufacturer, 2018
7.3. Global 3D Printed Drugs Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global 3D Printed Drugs Market Share (%), by Manufacturer, 2018
7.5. Global 3D Printed Drugs Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global 3D Printed Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –3D Printed Drugs Market: Regional Analysis
8.1. North America
8.1.1. North America 3D Printed Drugs Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America 3D Printed Drugs Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America 3D Printed Drugs Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America 3D Printed Drugs Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America 3D Printed Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America 3D Printed Drugs Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America 3D Printed Drugs Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America 3D Printed Drugs Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America 3D Printed Drugs Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America 3D Printed Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. 3D Printer Drug Machine
9.2. Fluke Calibration
9.2.1. Financials
9.2.2. Product portfolio
9.2.3. 3D Printed Drugs Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.2.4. 3D Printed Drugs Sales Market Share (%), 2014 - 2018
9.2.5. Business strategy
9.2.6. Recent developments
9.3. 3D Printer Drug Machine
9.4. Aprecia Pharmaceuticals
9.5. Hewlett Packard Caribe
9.6. BV
9.7. LLC
9.8. GlaxoSmithKline Plc.
9.9. FabRx Ltd.
9.10. Cycle Pharmaceuticals      
9.11. Others
 
10. Chapter – Market Research and Findings



This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.